ISOLUTE® HCX-Q is a mixed-mode sorbent providing clean extracts for strongly basic compounds (e.g. quaternary amines) from complex biological fluid samples using a dual retention mechanism.
ISOLUTE® HCX-Q combines non-polar (C8) and weak cation exchange retention (COO-) mechanisms to isolate strongly basic analytes from complex aqueous matrices such as urine and plasma.
Analytes are initially retained by a non-polar retention mechanism, with inorganic salts, polar interferences such as phospholipids and large molecular weight peptides and proteins passing directly through the sorbent bed. The pH is then adjusted to allow an ion exchange retention mechanism to retain the analyte(s). Non-polar interferences are removed using an organic solvent or organic solvent/water wash. Analytes are then eluted in an extra clean fraction.
ISOLUTE HCX-Q is available in a wide range of SPE columns and 96-well plate formats.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
986-0010-A | ISOLUTE® HCX-Q 100 mg/1 mL | 100 | 323 USD | Add to quote/cart |
986-0002-A | ISOLUTE® HCX-Q 25 mg/1 mL | 100 | 281 USD | Add to quote/cart |
986-0005-A | ISOLUTE® HCX-Q 50 mg/1 mL | 100 | 281 USD | Add to quote/cart |
986-0100-P01 | ISOLUTE®-96 HCX-Q 100 mg Fixed Well Plate | 1 | 407 USD | Add to quote/cart |
986-0025-P01 | ISOLUTE®-96 HCX-Q 25 mg Fixed Well Plate | 1 | 378 USD | Add to quote/cart |
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage